Related references
Note: Only part of the references are listed.Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis
Sergio Iannazzo et al.
ANTIVIRAL THERAPY (2013)
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir
Robert G. Gish et al.
ANTIVIRAL THERAPY (2013)
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-alpha 2a and adefovir
R. Bart Takkenberg et al.
ANTIVIRAL THERAPY (2013)
HBsAg Quantification to Predict Natural History and Treatment Outcome in Chronic Hepatitis B Patients
Michelle Martinot-Peignoux et al.
CLINICS IN LIVER DISEASE (2013)
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
Tai-Chung Tseng et al.
HEPATOLOGY (2013)
Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
Mei-Hsuan Lee et al.
HEPATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen Levels and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
Wai-Kay Seto et al.
HEPATOLOGY (2013)
Response-Guided Peginterferon Therapy in Hepatitis B e Antigen-Positive Chronic Hepatitis B Using Serum Hepatitis B Surface Antigen Levels
Milan J. Sonneveld et al.
HEPATOLOGY (2013)
Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
Patrick Marcellin et al.
HEPATOLOGY INTERNATIONAL (2013)
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA
Michelle Martinot-Peignoux et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs
Denis Ouzan et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel
M. Chudy et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
Maurizia R. Brunetto et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-nave, e antigen-positive patients
Michelle Martinot-Peignoux et al.
JOURNAL OF HEPATOLOGY (2013)
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment
Wai-Kay Seto et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D
Lucio Boglione et al.
LIVER INTERNATIONAL (2013)
The role of HBsAg quantification for monitoring natural history and treatment outcome
Michelle Martinot-Peignoux et al.
LIVER INTERNATIONAL (2013)
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype
Milan J. Sonneveld et al.
ANTIVIRAL THERAPY (2012)
Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy
Jinjun Chen et al.
ANTIVIRAL THERAPY (2012)
Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection
Yi-Cheng Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Harry L. A. Janssen et al.
GUT (2012)
New perspectives in the therapy of chronic hepatitis B
Pietro Lampertico et al.
GUT (2012)
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
Vincent Rijckborst et al.
JOURNAL OF HEPATOLOGY (2012)
High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
Wai-Kay Seto et al.
PLOS ONE (2012)
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
Y. Liang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen-Positive Patients
Teerha Piratvisuth et al.
HEPATOLOGY (2011)
Quantitative Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers in Prediction of Treatment Response to Entecavir
Jung Min Lee et al.
HEPATOLOGY (2011)
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum
Karsten Wursthorn et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B
Milan J. Sonneveld et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
DEFINITION OF INACTIVE HEPATITIS B CARRIER BY SERUM HBSAG AND HBVDNA LEVELS - A LONG-TERM FOLLOW-UP STUDY ON HBSAG SEROCLEARANCE
H. L. -Y. Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
NEPTUNE STUDY: ON-TREATMENT HBSAG LEVEL ANALYSIS CONFIRMS PREDICTION OF RESPONSE OBSERVED IN PHASE 3 STUDY OF PEGINTERFERON ALFA-2A IN HBEAG-POSITIVE PATIENTS
E. Gane et al.
JOURNAL OF HEPATOLOGY (2011)
Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
Roeland Zoutendijk et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients
A. Gramenzi et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B
H. L. -Y. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
Gloria Woo et al.
GASTROENTEROLOGY (2010)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
Vincent Rijckborst et al.
HEPATOLOGY (2010)
A Longitudinal Study on the Natural History of Serum Hepatitis B Surface Antigen Changes in Chronic Hepatitis B
Henry Lik-Yuen Chan et al.
HEPATOLOGY (2010)
Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline
Milan J. Sonneveld et al.
HEPATOLOGY (2010)
Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients
Karsten Wursthorn et al.
HEPATOLOGY (2010)
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
Wei Cai et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks
Rami Moucari
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D-PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B
P. Lampertico et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
Tin Nguyen et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
Jerzy Jaroszewicz et al.
JOURNAL OF HEPATOLOGY (2010)
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha 2a
Rami Moucari et al.
ANTIVIRAL THERAPY (2009)
Expression of Hepatitis B Virus Surface Antigen (HBsAg) from Genotypes A, D and F and Influence of Amino Acid Variations Related or Not to Genotypes on HBsAg Detection
Natalia M. Araujo et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
Rami Moucari et al.
HEPATOLOGY (2009)
Hepatitis B Virus Surface Antigen Levels: A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B
Maurizia Rossana Brunetto et al.
HEPATOLOGY (2009)
Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B
Pisit Tangkijvanich et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
G. K. K. Lau et al.
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
Rami Moucari et al.
JOURNAL OF HEPATOLOGY (2009)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients
Stephanos J. Hadziyannis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
HJ Flink et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
M Martinot-Peignoux et al.
JOURNAL OF HEPATOLOGY (2002)
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
MR Brunetto et al.
JOURNAL OF HEPATOLOGY (2002)
Management of hepatitis B: 2000 - Summary of a workshop
AS Lok et al.
GASTROENTEROLOGY (2001)
Share Paper
